Rhotekin 2, a novel GTPase effector involved in resistance to apoptosis
thesis
posted on 2008-01-01, 00:00authored byFiona M. Collier
This thesis describes the discovery, characterization, and function of a new protein, Rhotekin 2. It is a signaling protein with a significant role in resistance to cell death in human lymphocytes and therefore may be a potential new target in future treatments of immune diseases such a HIV and leukemia.